Last reviewed · How we verify
Moderna COVID-19 mRNA vaccine — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Moderna COVID-19 mRNA vaccine (Moderna COVID-19 mRNA vaccine) — Methodist Health System.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Moderna COVID-19 mRNA vaccine TARGET | Moderna COVID-19 mRNA vaccine | Methodist Health System | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Moderna COVID-19 mRNA vaccine CI watch — RSS
- Moderna COVID-19 mRNA vaccine CI watch — Atom
- Moderna COVID-19 mRNA vaccine CI watch — JSON
- Moderna COVID-19 mRNA vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Moderna COVID-19 mRNA vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/moderna-covid-19-mrna-vaccine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab